What is Trovan used for?
The TROVAN/ZITHROMAX Compliance Pak refers to a specific dual treatment for uncomplicated urethral gonorrhea in males and endocervical and rectal gonorrhea in females caused by Neisseria gonorrhoeae and non-gonoccocal urethritis/cervicitis caused by Chlamydia trachomatis.
Is Nigeria sues Pfizer?
The Nigerian government is suing the world’s largest drug manufacturer, Pfizer, for allegedly carrying out illegal trials of an anti-meningitis drug that killed or disabled children. Trovan was approved in the US in 1997 for use by adults but not children. …
Why was the Pfizer case unethical?
The suit charges that Pfizer did not obtain informed consent from the sick children’s parents and that a failure to adhere to the study protocol resulted in brain damage, hearing loss and the death of 11 of the 2,000 children in the study.
Is Prempro safe?
Prempro may increase your risk of developing a condition that may lead to uterine cancer. Report any unusual vaginal bleeding right away. Using Prempro can increase your risk of blood clots, stroke, or heart attack, or cancer of the breast, uterus, or ovaries.
What is the prodrug name for Trovan tablets?
Trovan is available as Trovan Tablets (trovafloxacin mesylate) for oral administration and as Trovan I.V. (alatrofloxacin mesylate injection), a prodrug of trovafloxacin, for intravenous administration.
Why was Trovan withdrawn from the market in 2001?
Summary. Trovafloxacin mesylate (Trovan) is a medication prescribed to treat a variety of infections. Trovan was withdrawn from the Markets worldwide in 2001 because of the risk of liver failure in patients taking Trovan.
Who is the manufacturer of trovafloxacin brand name?
Trovafloxacin is sold under the brand name Trovan®, manufactured by Pfizer. The sections below will provide you with more specific information and guidelines related to trovafloxacin and its correct use. Please read them carefully.
Are there any long term effects of Trovan use?
Trovan-ASSOCIATED LIVER INJURY HAS BEEN REPORTED WITH BOTH SHORT-TERM AND LONG-TERM DRUG EXPOSURE. Trovan USE EXCEEDING 2 WEEKS IN DURATION IS ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF SERIOUS LIVER INJURY. LIVER INJURY HAS ALSO BEEN REPORTED FOLLOWING Trovan RE-EXPOSURE.